Publication | Open Access
Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks
42
Citations
32
References
2011
Year
PharmacologyImmunologyPegylated Interferon Alfa-2bIndividualizing TreatmentAntiviral TherapyTreatment OptionPharmacotherapyMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1